Related Experiment Video

Updated: Jul 27, 2026

Detection of Neuritic Plaques in Alzheimer's Disease Mouse Model
06:02

Detection of Neuritic Plaques in Alzheimer's Disease Mouse Model

Published on: July 26, 2011

Chemotactic signaling, microglia, and Alzheimer's disease senile plaques: is there a connection?

Magdalena Luca1, Alexandra Chavez-Ross, Leah Edelstein-Keshet

  • 1Massachusetts College of Pharmacy and Health Sciences, School of Arts and Sciences, 179 Longwood Avenue, Boston, MA 021 15-5896, USA. magdalena.luca@mcp.edu

Bulletin of Mathematical Biology
|July 24, 2003
PubMed

Insights

Microglia aggregation in Alzheimer's disease (AD) may form from complex chemical signals. Our model shows periodic patterns can emerge from attraction and repulsion, offering insights into AD pathology.

Area of Science:

  • Neuroscience
  • Computational Biology
  • Biochemistry

Background:

  • Microglia, the brain's immune cells, are implicated in Alzheimer's disease (AD) pathogenesis.
  • Inflammation and the accumulation of chemical signals are hallmarks of AD senile plaques.

Purpose of the Study:

  • To model the conditions driving microglia aggregation and chemical accumulation in AD.
  • To understand the role of chemotaxis in the formation of AD pathological features.

Main Methods:

  • Development of a mathematical model for cell chemotaxis with chemoattractant and chemorepellent signals.
  • Application of linear stability analysis to predict pattern formation.
  • Numerical simulations to explore cell and chemical distribution dynamics.

Main Results:

  • The model predicts that periodic patterns in microglia and chemical distributions can arise.
  • These patterns are dependent on local attraction, long-range repulsion, and signal diffusion properties.
  • The model's predictions are evaluated using biological parameters relevant to AD.

Conclusions:

  • Chemotactic signaling dynamics, including attraction and repulsion, can explain microglia aggregation in AD.
  • The developed model provides a framework for understanding the spatial organization of pathological features in Alzheimer's disease.
  • Further research can refine the model using specific biological parameters for enhanced predictive power.

More Related Videos

Correlative Light and Electron Microscopy to Study Microglial Interactions with β-Amyloid Plaques10:52

Correlative Light and Electron Microscopy to Study Microglial Interactions with β-Amyloid Plaques

Published on: June 1, 2016

Quantitative 3D In Silico Modeling (q3DISM) of Cerebral Amyloid-beta Phagocytosis in Rodent Models of Alzheimer's Disease09:33

Quantitative 3D In Silico Modeling (q3DISM) of Cerebral Amyloid-beta Phagocytosis in Rodent Models of Alzheimer's Disease

Published on: December 26, 2016

Related Concept Videos

Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...